Management and Treatment of Chronic HBV and HCV Co-Infection and the Impact of Anti-Viral Therapy

Management and Treatment of Chronic HBV and HCV Co-Infection and the Impact of Anti-Viral Therapy Curr Hepatology Rep (2017) 16:169–177 DOI 10.1007/s11901-017-0352-z HEPATITIS B (J LIM, SECTION EDITOR) Management and Treatment of Chronic HBV and HCV Co-Infection and the Impact of Anti-Viral Therapy 1 2 Mitchell L. Shiffman & Nadege T. Gunn Published online: 19 July 2017 Springer Science+Business Media, LLC 2017 . . Abstract Keywords Hepatitis B virus Hepatitis C virus . . Purpose of Review Recent reports have demonstrated that Co-infection Direct-acting anti-viral agents Peginterferon chronic hepatitis B virus (HBV) can flare or reactivate when alpha Ribavarin chronic hepatitis C virus (HCV) is treated with direct-acting anti-viral agents (DAAs). Understanding HBV and HCV co- infection is therefore important. Epidemiology Recent Findings Although 40–60% of patients with chronic HCV have been previously exposed to HBV; only about 1– Chronic viral hepatitis B (HBV) and C (HCV) collectively 6% has serologic evidence of co-infection. In some patients represent the most common cause of chronic liver disease with co-infection, both HBsurface antigen and HBV DNA worldwide. An estimated 350 million persons have chronic may be suppressed to undetectable levels by HCV. Complete HBV [1]. The areas of the world with the highest prevalence serologic screening for HBV should be performed in all pa- for HBV http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Hepatology Reports Springer Journals

Management and Treatment of Chronic HBV and HCV Co-Infection and the Impact of Anti-Viral Therapy

Loading next page...
 
/lp/springer_journal/management-and-treatment-of-chronic-hbv-and-hcv-co-infection-and-the-Iop4hlUoh6
Publisher
Springer US
Copyright
Copyright © 2017 by Springer Science+Business Media, LLC
Subject
Medicine & Public Health; Hepatology
eISSN
2195-9595
D.O.I.
10.1007/s11901-017-0352-z
Publisher site
See Article on Publisher Site

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial